Alutacenoic acids A and B, rare naturally occurring cyclopropenone derivatives isolated from fungi: Potent non-peptide factor XIIIa inhibitors [21]

Journal of the American Chemical Society

Volumn 122, Issue 8, 2000, Pages 1842-1843

  Kogen, Hiroshi ^a   Kiho, Toshihiro ^a   Tago, Keiko ^a   Miyamoto, Shuichi ^a   Fujioka, Tomoyuki ^a   Otsuka, Noriko ^a   Suzuki Konagai, Keiko ^a   Ogita, Takeshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALUTACENOIC ACID A; ALUTACENOIC ACID B; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 13A; CYCLOPROPENONE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; DRUG ISOLATION; DRUG POTENCY; DRUG SYNTHESIS; EUPENICILLIUM ALUTACEUM; FUNGUS; ISCHEMIC HEART DISEASE; LETTER; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; THROMBOSIS;

EID: 0034095071     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja992355s     Document Type: Letter

References (53)

1. (a) Leidy, E. M.; Stern, A. M.; Friedman, P. A.; Bush, L. R. Thromb. Res. 1990, 59, 15-26.
2. (b) Greenberg, C. S.; Birckbichler, P. J.; Rice, R. H. FASEB J. 1991, 5, 3071-3077.
3. (c) Aeschliman, D.; Paulsson, M. Thromb. Haemostasis 1994, 71, 402-415.
4. (d) Yee, V. C.; Pedersen, L. C.; Trong, I. L.; Bishop, P. D.; Stenkamp, R. E.; Teller, D. C. Proc. Natl. Acad Sci. U.S.A. 1994, 91, 7296-7300.
5. Curtis, C. G.; Brown, K.; Credo, R. B.; Domanik, R. A.; Gray, A.; Stenberg, P.; Lorand, L. Biochemistry 1974, 13, 3774-3780.
6. (a) Bruner-Lorand, J.; Pilkington, T. R. E.; Lorand, L. Nature (London) 1966, 210, 1273-1274.
7. (b) Gladner, J. A.; Nosssal, R. Thromb. Res. 1983, 30, 273-288.
8. (c) Shen, L.; Lorand, L. J. Clin. Invest. 1983, 71, 1336-1341.
9. (a) Kloczko, J.; Wojtukiewicz, M.; Bielawiec, M.; Zarzycka, B.; Kinalska, I. Acta Haematol. 1986, 76, 81-85.
10. (b) Francis, C. W.; Connaghan, D. G.; Scott, W. L.; Marder, V. J. Circulation 1987, 75, 1170-1177.
11. (c) Kloczko, J.; Wojtukiewicz, M.; Bielawiec, M.; Zuch, A. Thromb. Res. 1988, 51, 575-581.
12. Synthetic peptides: Achyuthan, K. E.; Slaughter, T. F.; Santiago, M. A.; Enghild, J. J.; Greenberg, C. S. J. Biol. Chem. 1993, 268, 21284-21292. Natural peptide: Finney, S.; Seale, L.; Sawyer, R. T.; Wallis, R. B. Biochem. J. 1997, 324, 797-805.
13. Synthetic peptides: Achyuthan, K. E.; Slaughter, T. F.; Santiago, M. A.; Enghild, J. J.; Greenberg, C. S. J. Biol. Chem. 1993, 268, 21284-21292. Natural peptide: Finney, S.; Seale, L.; Sawyer, R. T.; Wallis, R. B. Biochem. J. 1997, 324, 797-805.
14. (a) Leidy, E. M.; Stern, A. M. Thromb. Res. 1990, 59, 15-26.
15. (b) Shebuski, R. J.; Sitko, G. R.; Claremon, D. A.; Baldwin, J. J.; Remy, D. C.; Stern, A. M. Blood 1990, 75, 1455-1459.
16. (c) Freund, K. F.; Doshi, K. P.; Gaul, S. L.; Claremon, D. A.; Remy, D. C.; Baldwin, J. J.; Pitzenberger, S. M.; Stern, A. M. Biochemistry 1994, 33, 10109-10119.
17. (a) Matsumae, A.; Kamio, Y.; Hata, T. J. J. Antibiot. Ser. A 1963, 16, 236-238.
18. (b) Sano, Y.; Nomura, S.; Kamio, Y.; Omura, S.; Hata, T. J. Antibiot. 1967, 20, 344-348.
19. (c) Arison, B. H.; Omura, S. J. Antibiot. 1974, 27, 28-30.
20. (d) Omura, S. Methods Enzymol. 1981, 72, 520-532.
21. Tymiak, A. A.; Tuttle, J. G.; Kimball, S. D.; Wang, T.; Lee, V. G. J. Antibiot. 1993, 46, 204-206.
22. 3OD) δ (ppm) 26.5, 27.1, 28.1, 30.2, 30.4, 30.5, 35.5, 150.2, 161.8, 171.4, 178.2. 1b was stored in a freezer (-20 °C) without decomposition for at least 2 years.
23. For the factor XIIIa assay utilized for this study, see: Usui, T.; Takagi, J.; Saito, Y. J. Biol. Chem. 1993, 268, 12311-12316.
24. Alutacenoic acid B (1b) is also isolated from Aspergillus fumigatus Fresenius.
25. For a detailed study on structure determination by NMR, see the Supporting Information.
26. (a) Breslow, R.; Haynie, R.; Mirra, J. J. Am. Chem. Soc. 1959, 81, 247-248.
27. (b) Greenberg, A.; Tomkins, R. P. T.; Dobrovolny, M.; Liebman, J. F. J. Am. Chem. Soc. 1983, 105, 6855-6858.
28. (c) Staley, W. S.; Nordon, T. D.; Taylor, W. H.; Harmony, M. D. J. Am. Chem. Soc. 1987, 109, 7641-7647.
29. (d) Wiberg, K. B.; Marquez, M. J. Am. Chem. Soc. 1998, 120, 2932-2938.
30. Review: (a) Krebs, A. W. Angew. Chem., Int. Ed. Engl. 1965, 4, 10-22. (b) Potts, K. T.; Baum, J. S. Chem. Rev. 1974, 74, 189-213. (c) Eicher, T.; Weber, J. L. Top. Curr. Chem. 1975, 57, 1-109.
31. Review: (a) Krebs, A. W. Angew. Chem., Int. Ed. Engl. 1965, 4, 10- 22. (b) Potts, K. T.; Baum, J. S. Chem. Rev. 1974, 74, 189-213. (c) Eicher, T.; Weber, J. L. Top. Curr. Chem. 1975, 57, 1-109.
32. Review: (a) Krebs, A. W. Angew. Chem., Int. Ed. Engl. 1965, 4, 10- 22. (b) Potts, K. T.; Baum, J. S. Chem. Rev. 1974, 74, 189-213. (c) Eicher, T.; Weber, J. L. Top. Curr. Chem. 1975, 57, 1-109.
33. (a) Isaka, M.; Matsuzawa, S.; Yamago, S.; Ejiri, S.; Miyachi, Y.; Nakamura, E. J. Org. Chem. 1989, 54, 4727-4729.
34. (b) Isaka, M.; Ando, R.; Morinaka, Y.; Nakamura, E. Tetrahedron Lett. 1991, 32, 1339-1342.
35. (c) Isaka, M.; Ejiri, S.; Nakamura, E. Tetrahedron 1992, 48, 2045-2057.
36. (d) Tokuyama, H.; Isaka, M.; Nakamura, E. J. Antibiot. 1992, 45, 1148-1154.
37. (a) Okuda, T.; Yoneyama, Y.; Fujiwara, A.; Furumai, T. J. Antibiot. 1984, 37, 712-717.
38. (b) Okuda, T.; Yoneyama, Y.; Fujiwara, A.; Furumai, T.; Maruyama, H. B. J. Antibiot. 1984, 37, 718-722.
39. (c) Okuda, T.; Shimma, N.; Furumai, T. J. Antibiot. 1984, 37, 723-727.
40. Formula Presented
41. Bohlmann, F.; Jakupovic, J.; Mueller, L.; Schuster, A. Angew. Chem., Int. Ed. Engl. 1981, 20, 292-293.
42. Formula Presented
43. Compound 1d was derived from 4d, which was prepared by methylation of 4b. Further details, see the Supporting Information.
44. We also prepared various esters, amides, ethers, and acylamines. Further detailed study will be reported elsewhere.
45. Anelli, P. L.; Biffi, C.; Montanari, F.; Quici, S. J. Org. Chem. 1987, 52, 2559-2562.
46. obs varied hyperbolically with inhibitor concentration. A detailed study will be reported elsewhere.
47. obs varied hyperbolically with inhibitor concentration. A detailed study will be reported elsewhere.
48. obs varied hyperbolically with inhibitor concentration. A detailed study will be reported elsewhere.
49. (a) Yee, V. C.; Pedersen, L. C.; Bishop, P. D.; Stenkamp, R. E.; Teller, D. C. Thromb. Res. 1995, 78, 389-397.
50. (b) Weiss, M. S.; Metzner, H. J.; Hilgenfeld, R. FEBS Lett. 1998, 423, 291-296.
51. Compound 1d does not fit the active site well because of the steric repulsion of the methyl group.
52. Molecular Simulations Inc., USA.
53. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer, E. F., Jr.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. J. Mol. Biol. 1977, 112, 535.